Moderna | MRNA - Market Capitalization


Moderna reported $60.31B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
Arrowhead Research USD 10.84B 664M Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Cspc Pharmaceutical CNY 99.86B 3.93B Aug/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 2.21T 464.84B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 26.84B 4.19B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pharma Mar EUR 1.39B 78.26M Aug/2026
Qiagen NV USD 8.47B 396.81M Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
United Therapeutics USD 24.42B 1.42B Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026
Zealand Pharma A/S 33.35B 12.51B Aug/2026